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Abstract 
Background: HFpEF is underpinned by detrimental skeletal muscle alterations that 
contribute to disease severity, yet underlying mechanisms and therapeutic treatments 
remain poorly established. This study used an animal model of HFpEF to better 
understand whether skeletal muscle abnormalities were: 1) fiber-type specific; and 2) 
reversible by various exercise training regimes.  
Methods and Results: Lean controls were compared to obese ZSF1 rats at 20 weeks, 
and 8 weeks later following sedentary, high-intensity interval training, or moderate-
continuous treadmill exercise. Oxidative-soleus and glycolytic-extensor digitorum longus 
(EDL) muscles were assessed for fiber size, capillarity, glycolytic metabolism, autophagy, 
and contractile function. HFpEF reduced fiber size and capillarity by 20-50% (P<0.05) in 
both soleus and EDL, but these effects were not reversed by endurance training. In 
contrast, both endurance training regimes in HFpEF attenuated the elevated lactate 
dehydrogenase activity observed in the soleus. Autophagy was downregulated in EDL and 
upregulated in soleus (P<0.05), with no influence following endurance training. HFpEF 
impaired contractile forces of both muscles by ~20 % (P<0.05) and these were not 
reversed by training.      
Conclusion: Obesity-related HFpEF was associated with detrimental structural, cellular, 
and functional alterations to both slow-oxidative and fast-glycolytic skeletal muscles that 
could not be reversed by endurance training.  
Word count: 198 of 200 
Key words: diastolic dysfunction; exercise training; HFpEF; obesity; soleus: ZSF1 
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Introduction  
The increasing prevalence of heart failure patients with preserve ejection fraction (HFpEF) 
despite no breakthrough in effective treatments is now recognized as a major unmet 
problem in cardiovascular medicine [1]. Cardiac-orientated drug interventions in large-
scale clinical trials in HFpEF have proven largely ineffective in terms of patient outcomes 
[2]. This has shifted focus towards possible treatment of “non-cardiac organs”, such as the 
skeletal muscle, endothelial, and pulmonary systems. Recent studies have now 
established functional and structural impairments are present in skeletal muscle from both 
patients and animal models of HFpEF [3-7]. Muscle-specific changes include fiber atrophy, 
adipose infiltration, oxidative to glycolytic fiber type shift, reduced capillary density, and 
mitochondrial dysfunction, which have also been closely correlated to the main symptom 
of exercise intolerance [5-8]. Interestingly, new evidence has confirmed the presence of a 
specific obesity-related HFpEF patient cohort [9]. Whether skeletal muscle alterations 
occur in this distinct phenotype is yet to be fully explored. Nevertheless, skeletal muscle 
maladaptations induced by HFpEF predispose patients towards a rapid depletion of high-
energy phosphates and earlier accumulation of fatigue inducing metabolites [10, 11]. 
Therefore identification of interventions to reverse such processes are a key therapeutic 
target in cardiovascular medicine.  
 
While evidence remains scarce, numerous skeletal muscle alterations induced by HFpEF 
can be prevented following exercise training. One study using a hypertensive rat model of 
HFpEF documented that high-intensity interval training (HIIT) attenuated mitochondrial 
impairments, which was associated with normalized contractile function and fatigue-
resistance [4]. However in this study exercise training was initiated before the onset of 
HFpEF (i.e. primary intervention) [4], which precluded answering the more clinically-
relevant question of whether exercise training reverses muscle impairments in HFpEF. 
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Further, HFpEF was induced by hypertension alone rather than the multiple co-morbidities 
(e.g., obesity, diabetes, renal dysfunction, and hypertension) that typically drive the 
development of this disease in most patients - particular in those with obesity-related 
HFpEF [9].  
 
This study, therefore, aimed to further characterize the underlying structural, metabolic, 
and molecular skeletal muscle alterations that occur in obesity-related HFpEF and 
determine whether endurance training could reverse impairments (i.e. secondary 
prevention). In this study, we used a recently established cardiometabolic obese-driven rat 
model of HFpEF [3, 12, 13]. The model closely resembles a typical patient phenotype, 
where cardiac impairments and exercise intolerance are underpinned by numerous co-
morbidities including obesity, type II diabetes, hypertension, and kidney dysfunction [14, 
15]. We specifically compared two skeletal muscles with differing metabolic profiles: the 
oxidative slow-twitch soleus in addition to the glycolytic fast-twitch extensor digitorum 
longus (EDL), in order to determine whether HFpEF induces fiber-type specific 
maladaptations.  
 
Methods 
Study design and animal model of HFpEF  
Procedures and experiments in this study were approved by the Norwegian Animal 
Research Authority, in accordance the European Directive 2010/63/EU. A full description 
of the present study design and animal cohort as well as the methods employed were 
recently described elsewhere [3]. Briefly, obese diabetic Zucker fatty/Spontaneously 
hypertensive heart failure F1 hybrid (ZSF1) rats (Charles River, Kingston, US) were used 
as a model to induce HFpEF, which occurs by 20 weeks of age [3, 12, 13]. Non-invasive 
echocardiography as well as invasive hemodynamics were used to confirm the presence 
of HFpEF, where left ventricular diastolic impairments and a preserved ejection fraction 
were confirmed alongside measures of obesity, hypertension, type II diabetes, and 
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exercise intolerance (as described in detail elsewhere [3]). The first part of the study 
assessed male obese ZSF1 rats (i.e., HFpEF, n=12) rats at 20 weeks of age compared to 
their lean strain-matched counterparts (i.e., controls; n=8). In the second part of the study, 
a further 4 groups were assessed at 28 weeks of age, which included lean rats compared 
to 3 groups of obese ZSF1 rats that performed either no exercise training (i.e., sedentary; 
n=13), high-intensity interval training (i.e., HFpEF+HIIT; n=11) or moderate continuous 
training (i.e., HFpEF+MCT; n=11). Exercise training was performed for 8 weeks (from 20-
28 weeks of age), which included HIIT (3 x per week; 4 intervals at 90% peak oxygen 
uptake ( ̇  peak) for 4 min, with 3 min recovery at 60%  ̇  peak) or MCT (5 x per week at 
60%  ̇  peak for 1 h) for a total of 8 weeks on a treadmill at a gradient of 25°, as previously 
described [3].  
 
Muscle function  
The right EDL and soleus were dissected and mounted vertically mounted in a buffer-filled 
organ bath between a hook and force transducer (FORT250, World Precision Instruments 
Inc., Berlin, Germany), with the output continuously recorded and digitized (PowerLab 
8/30, ADInstruments, Oxford, UK). In vitro muscle function was assessed by platinum 
electrodes stimulating the muscle with a supramaximal current (700 mA; 500 ms train 
duration; 0.25 ms pulse width) from a base stimulator (Grass S88, Grass Technologies, 
Warwick, USA) amplified via a high power bi-polar stimulator (701C, Aurora Scientific Inc., 
Aurora, Canada). The muscle bundle was set at an optimal length (Lo) equivalent to the 
maximal twitch force produced, after which bath temperature was increased to 25°C and a 
15 min thermo-equilibration period followed. A force-frequency protocol was then 
performed at 1, 15, 30, 50, 80, and 120 Hz respectively, separated with 1 min rest 
intervals. Following a 5 min rest period muscles then underwent a fatigue protocol over 5 
min (40 Hz every 2 s). Forces generated during the fatigue protocol were normalized to the 
initial force generated, to provide a relative assessment of fatigability.  
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Tissue analyses  
One portion of the left EDL and soleus were frozen immediately in liquid N2 for biochemical 
analyses. Frozen muscle samples were subsequently homogenized in lysis buffer (50 mM 
Tris, 150 mM sodium chloride, 1 mM EDTA, 1% NP-40, 0.25% sodium-deoxycholate, 
0.1% SDS, 1% Triton X-100; pH 7.4) containing a protease inhibitor mix (Inhibitor mix M, 
Serva, Heidelberg, Germany), sonicated, and centrifuged at 16,000 g for 5 min. The 
supernatant was isolated and protein content determined (BCA assay, Pierce, Bonn, 
Germany). Muscle homogenates (5 - 20 μg) mixed with loading buffer (126 mM Tris-HCl, 
20% glycerol, 4% SDS, 1.0% 2-mercaptoethanol, 0.005% bromophenol blue; pH 6.8) were 
separated by SDS-polyacrylamide gel electrophoresis for 1.5 h at 90 V. Proteins were 
transferred to a polyvinylidene fluoride membrane (PVDF) and incubated overnight at 4°C 
with primary antibodies for the LC3 (1:1000, Novus Biologicals, Cambridge, UK), where 
the relative ratio of LC3 in its content form of II/I was used as a marker of autophagy. 
Membranes were subsequently incubated with a horseradish peroxidase-conjugated 
secondary antibody and specific bands visualized by enzymatic chemiluminescence 
(Super Signal West Pico, Thermo Fisher Scientific Inc., Bonn, Germany) and densitometry 
quantified using a 1D scan software package (Scanalytics Inc., Rockville, USA). In 
addition, enzyme activities for lactate dehydrogenase (LDH) were measured 
spectrophotometrically as a measure of glycolytic metabolism, as previously described 
[16]. Protein and enzyme activity data are presented as fold change relative to the 
respective control group. In addition, a portion of the EDL and soleus fixed in 4% PBS-
buffered formalin and paraffin-embedded were used for histological analyses of cross-
sectional area (CSA). Briefly, sections of 3 µm were cut, mounted on glass cover slips, 
and stained for H&E for fiber CSA to be calculated. In addition, sections were stained with 
an antibody against von Willebrand factor (vWF; 1/500, Santa Cruz) for capillaries to be 
visualised, with the capillary to fiber ratio subsequently determined.   
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Statistical analyses  
Analyses were performed by SPSS version 22 (SPSS Inc., Chicago, IL, USA). Data are 
presented as mean±SEM. Between-group differences were assessed by unpaired 
Student’s t-test at 20 weeks or by one-way ANOVA at 28 weeks, while data presented as 
ratios were analyzed by appropriate non-parametric tests (Mann-Whitney or Kruskal-
Wallis). Muscle function (force-frequency and force-time relationships) was assessed by 
two-way repeated measures ANOVA (group X frequency or group X time). Post hoc 
comparisons were calculated using Bonferroni-corrected tests.  
 
Results  
Animal model of HFpEF 
Obese ZSF1 rats developed typical signs of HFpEF at 20 and 28 weeks, independent of 
exercise training. These data have already been published elsewhere and the reader is 
referred to this manuscript for more expansive details characterizing the current cohort of 
rats [3]. Briefly, at 28 weeks compared to lean controls all HFpEF groups (sedentary, MCT, 
HIIT) demonstrated evidence (P<0.05) of diastolic dysfunction (E/E’: 15±1 vs. 25±1, 25±2, 
23±1, respectively; P<0.0001), LV hypertrophy (23±1 vs. 28±1, 28±1, 29±1 mg/mm of tibia 
length, respectively; P<0.0001), obesity (body weight: 465±1 vs. 590±15, 591±17, 599±12 
g, respectively; P<0.0001), diabetes (fasting blood glucose; 4.1±0.2 vs. 6.4±0.5, 5.5±0.3, 
7.8±0.7 mmol/L, respectively; P<0.0001), and hypertension (systolic blood pressure: 
158±14 vs. 181±15, 176±13,183±18 mmHg, respectively; P=0.008), in the presence of 
normal LVEF (66±2 vs. 75±2, 74±2, 72±3~70 %, respectively). Importantly, exercise 
capacity as assessed by  ̇  peak was reduced (P<0.0001) in sedentary HFpEF rats 
compared to controls by ~30% (38±1 vs. 49±1 mL kg-1min-1, respectively). However, 8 
weeks of exercise training resulted in a ~15 %  ̇  peak increase (P=0.004) in both the MCT 
and HIIT groups compared to sedentary HFpEF rats (44±1 and 44±1 vs. 38±1 mL kg-1min-
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1, respectively). All of the changes mentioned above between control and sedentary 
HFpEF rats were also present at 20 weeks. 
 
In addition, compared to control rats, muscle wet-weights at 20 weeks were reduced in 
HFpEF for both the EDL (258±29 vs. 174±21 mg, respectively; P<0.0001) and soleus 
(219±11 vs. 180±19 mg, respectively; P<0.0001). Similarly, at 28 weeks control rats 
maintained higher (P<0.05) muscle wet-weights compared to all HFpEF groups 
(sedentary, MCT, HIIT) such that training had no impact on muscle mass for the EDL 
(241±8 vs. 156±2, 164±3, 161±3 mg, respectively; P<0.0001) or soleus (221±4 vs. 170±4, 
184±6, 188±4 mg, respectively; P<0.0001).  
 
Glycolytic and oxidative skeletal muscle alterations in HFpEF 
At 20 weeks, we observed numerous structural, metabolic, and molecular alterations in the 
skeletal muscles of HFpEF rats, both in the glycolytic fast-twitch EDL as well as the 
oxidative slow-twitch soleus muscle. Representative muscle sections of the EDL are 
presented in Fig. 1A-B for control and HFpEF rats, respectively. Compared to controls, 
HFpEF rats demonstrated fiber atrophy by ~50 % (P<0.0001; Fig. 1C) and a reduction in 
capillarity by ~20 % (P=0.001; Fig. 1D) in the EDL muscle. While not significant, the 
activity of the glycolytic enzyme LDH tended to be higher in the EDL of HFpEF rats 
(P=0.07; Fig. 1E), with protein levels of LC3 II/I ratio (an index of autophagy) showing a 
reduction of ~15 % in HFpEF compared to the control rats (P=0.049; Fig. 1F). These 
structural and molecular changes likely contributed to the lower force generated in the EDL 
muscle, with maximal forces reduced by ~15 % (P=0.001; Fig. 1G) while relative fatigue 
was unaffected (P=0.401; Fig. 1H). Similarly, the predominately oxidative soleus muscle 
also showed numerous alterations in HFpEF, but to a lesser degree. Representative 
muscle sections of the soleus from control and HFpEF rats is presented in Fig. 2A-B. 
Compared to controls, the soleus in HFpEF demonstrated a ~40 and 15 % reduction in 
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fiber cross sectional area and capillarity, respectively (P<0.0001 and P=0.002, 
respectively; Fig. 2B-C). In contrast, while LDH activity and LC3 II/I protein levels were not 
different between groups (P=0.791 and P=0.621; Fig. 2E-F), maximal soleus force was 
reduced by ~20 % in HFpEF compared to control rats (P=0.006; Fig. 2G) yet fatigability 
remained unchanged (P=0.767; Fig. 2H).  
 
Can exercise training reverse skeletal muscle impairments in HFpEF? 
At 28 weeks, following 8 weeks of either sedentary, HIIT, or MCT regimes, the EDL 
muscle (see Fig. 3A for representative sections) in HFpEF rats showed no apparent 
benefit from exercise training: the observed fiber atrophy (P<0.0001) and reduced 
capillarity (P=0.016) were not reversed compared to control values (Fig. 3B-C), while 
limited effects were observed on markers of glycolytic metabolism (P=0.316) and 
autophagy (P=0.066; Fig. D-E). As one would expect, therefore, EDL muscle weakness 
and fatigability were not influenced with exercise training in HFpEF, with evidence of 
impaired force production (P<0.004) and greater fatigability (P<0.009) in the HFpEF 
groups compared to controls (Fig. 3F-G). In line with these findings, the oxidative soleus 
muscle (see Fig. 4A for representative sections) also showed limited benefits following 
exercise training in the HFpEF rats: HIIT or MCT were unable to increase fiber cross-
sectional area (P=0.003) or capillarity (P=0.010) back towards control values (Fig.4B-C). In 
contrast, the exercise training regimes attenuated activity of the glycolytic enzyme LDH, 
which remained elevated in the soleus of sedentary HFpEF rats relative to controls 
(P=0.004; Fig. 4D). Yet exercise training did not reduce autophagy activation, with protein 
levels of the LC3 II/I ratio elevated across all three HFpEF groups compared to controls in 
the soleus (P=0.016; Fig. 4E). As such, the lower contractile forces observed in the soleus 
from HFpEF animals compared to healthy rats at 20 weeks were not overcome by 8 weeks 
of exercise training (P=0.003; Fig. 4F), which was also similar for fatigability (P=0.001; Fig 
4G).    
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Discussion 
This is the first study to characterize fiber type-specific skeletal muscle alterations in a rat 
model of HFpEF and to further assess the efficacy of various exercise training regimes to 
reverse these deficits. The main finding of this study is that HFpEF caused detrimental 
alterations to both slow-oxidative and fast-glycolytic skeletal muscles including fiber 
atrophy, impaired capillarity, a shift towards glycolytic metabolism, and autophagy 
dysregulation, which expands upon our current knowledge collected from both patient and 
animal studies [3-8]. These structural, metabolic, and proteostasis changes likely 
contributed, at least in part, to the greater muscle weakness and fatigability that we also 
observed in HFpEF rats. Somewhat surprisingly 8 weeks of exercise training (either high- 
or moderate-intensity treadmill running) was unable to attenuate many of these muscle-
specific deficits, which likely provides a rationale for why muscle dysfunction could not be 
overcome. Overall, therefore, these data: 1) provide novel underlying mechanisms that 
may be responsible for skeletal muscle dysfunction in HFpEF: 2) confirm that glycolytic 
and oxidative muscles are both affected in HFpEF; 3) demonstrate exercise training to be 
an ineffective tool in reversing skeletal muscle impairments in this experimental model.   
 
Skeletal muscle dysfunction in HFpEF: oxidative vs. glycolytic  
Data from vastus lateralis biopsies have shown that when compared to age-matched 
controls, patients with HFpEF demonstrate reduced mitochondrial content, lower 
mitochondrial fusion proteins, a shift from oxidative to glycolytic fibers, and impaired 
capillarity [5-7]. Recent data have also suggested that a distinct obesity-related HFpEF 
patient cohort exists [9], but no data are available to support whether skeletal muscle 
alterations specific to this phenotype develop. In the current study, therefore, we used an 
obese-specific rat model of HFpEF to provide novel evidence that skeletal muscle 
impairments also occur in this phenotype, but also extend current knowledge in HFpEF to 
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show that both oxidative as well as glycolytic muscles are afflicted. While both the soleus 
and EDL were severely affected by fiber atrophy and lower capillarity, it is important to 
note that the glycolytic EDL demonstrated greater susceptibility. Indeed, previous data 
have shown the oxidative soleus to be better protected against impairments induced by 
heart failure with reduced ejection fraction (HFrEF) compared to glycolytic muscles [17], 
with our data tending to support this view in HFpEF. Our data also showed a strong trend 
for the glycolytic enzyme lactate dehydrogenase activity to be increased in HFpEF (both in 
soleus and EDL), which supports recent magnetic resonance imaging studies where an 
earlier depletion of high-energy phosphates occurred during the onset of exercise in 
HFpEF patients [10, 11]. 
 
An additional novel finding in the present study was revealing that other molecular 
signaling pathways may be involved in the muscle remodeling process induced by HFpEF. 
For example autophagy (as assessed by the ratio of LC3 II/I protein expression) was 
differentially regulated between fiber types during HFpEF. Autophagy is a catabolic 
process that degrades cytoplasmic proteins, however basal flux is key to maintain cell 
homeostasis. Previous studies in mice have shown that either excessive or deficient levels 
of autophagy can induce skeletal muscle atrophy and functional deficits [18, 19]. 
Collectively, therefore, our data suggest that HFpEF could modulate autophagy levels in a 
fiber-type specific manner via a signaling pathway not yet characterized in this disease. 
We speculate the significant increase of autophagy in the soleus but decrease in the EDL 
may have contributed, at least in part, to the muscle atrophy and dysfunction observed in 
HFpEF. Interestingly, previous data have shown that autophagic flux differs between 
oxidative and glycolytic muscles, which supports the suggestion that HFpEF could 
modulate this process in a fiber-dependent manner [20]. Moreover our findings also 
suggest that HFpEF could induce muscle alterations in both a fiber- and time-dependent 
manner determined by disease progression. For example, the glycolytic EDL was more 
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susceptible to impairments earlier in the disease (i.e., 20 weeks), whereas the oxidative 
soleus only exhibited alterations at a later time point (i.e. 28 weeks). Interestingly, only at 
28 weeks did the soleus demonstrate a significant increase in LDH activity and autophagic 
flux in HFpEF rats, which were not apparent at 20 weeks. The mechanism underlying 
these time-dependent changes remain unclear, however it may be related to the chronic 
pro-inflammatory state that accompanies the HFpEF phenotype [21], which given enough 
time would be expected to impact even the most resistant of all muscle fibers.  
 
Exercise training in HFpEF to reverse skeletal muscle impairments  
In the present study, exercise training conferred no significant benefits to either glycolytic 
or oxidative muscles, which was generally consistent in terms of structural, metabolic, 
autophagic, and functional measures. We did observe that glycolytic enzyme activity of 
lactate dehydrogenase was significantly attenuated in the soleus muscle of HFpEF rats 
that performed HIIT or MCT, which suggests a shift towards oxidative metabolism 
following exercise training. While the effects of exercise training to reverse skeletal muscle 
impairments in HFpEF remain largely unestablished, previous data in a hypertensive rat 
model of HFpEF showed endurance training was protective against reductions in soleus 
mitochondrial content and fatigability [4]. As the current study’s main focus was not on 
muscle mitochondrial adaptations, we cannot rule out the possibility that exercise training 
induced a shift towards an oxidative phenotype in the trained HFpEF rats, such that 
improvements in mitochondrial function/content or a shift towards increased oxidative 
slow-twitch fibers occurred. However, as part of another study using the same HFpEF rats 
[3], we have previously documented that citrate synthase activity (a marker of 
mitochondrial content) was not significantly increased in the soleus post-training. These 
findings, together with those we present here, seem to support therefore that a metabolic 
inflexibility may exist in this specific animal model with obesity-related HFpEF. Indeed, 
whether the lack of skeletal muscle adaptations we found in this study is specific to the 
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current HFpEF experimental model remains unknown, but the potential co-morbidities that 
occur in these animals such as obesity, diabetes, hypertension and renal dysfunction may 
prove too overwhelming for exercise training to be beneficial in only 8 weeks. In support, 
we recently reported the diaphragm was unable to benefit from exercise training in the 
same model [3], suggesting skeletal muscle adaptations in this model are not achieved 
with 8 weeks of endurance exercise training. Whether these findings, therefore, translate 
to patients with a specific obese-related HFpEF phenotype remains to be confirmed, but 
warrants further attention.  
 
Clinical translation and new insights 
In terms of clinical translation, our findings strongly support a number of muscle-specific 
changes reported to occur in HFpEF patients, as assessed from leg biopsies (e.g., fiber 
atrophy, reduced capillarity) [5-7], but also extend current knowledge in HFpEF by 
providing new findings on fiber-type specific adaptations (i.e., oxidative vs. glycolytic) as 
well as new mechanistic insight into the underlying signaling pathways (e.g., dysregulation 
in autophagy, upregulation of glycolytic enzymes). Up until now, patient and animal studies 
in HFpEF had drawn conclusions based upon a single muscle group (i.e., the vastus 
lateralis in patients and the soleus in animal models) [3-8]. As such, it was unknown 
whether other limb muscles composed of different fiber types showed similar impairments 
in HFpEF. The current study, therefore, provides new evidence that shows skeletal muscle 
remodeling in HFpEF is fiber-type dependent, with fast-twitch glycolytic fibers impacted 
earlier and to a greater degree. This adds additional insight by suggesting muscle groups 
composed of fast-twitch fibers should be primarily targeted during cardiac rehabilitation in 
HFpEF patients, as these may be more susceptible to impairments. Future patient studies 
should therefore focus on sampling various muscle groups in order to characterize the role 
of fiber-type specific adaptations in HFpEF.  
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Perhaps the most novel yet controversial finding of the present study is that it challenges 
the prevalent view that endurance training can be used as a treatment for muscle 
dysfunction in HFpEF [22]. In fact, our data support the recent suggestion that more work 
in the area is required to establish the benefit of exercise training in treating muscle 
dysfunction in HFpEF [23]. Specifically, here we found endurance training was unable to 
rescue muscle dysfunction and attenuate detrimental structural remodeling induced by 
HFpEF, irrespective of the exercise regime performed. While it is clearly established that 
endurance training in patients with HFpEF improves exercise capacity and quality of life 
[23-29], the role for this in the disease to rescue muscle dysfunction still remains unclear. 
Our current experimental data also found 8 weeks of endurance training (either HIIT or 
MCT) in HFpEF was able to increase  ̇  peak by ~15% (which mirrors the increase seen in 
patients after training [23], thus supporting clinical translation of our findings). Clearly, 
however, the lack of improvements we found in both oxidative and glycolytic skeletal 
muscles post-training in HFpEF would suggest a limited role of improved muscle function 
as a central mechanism underlying the increased exercise capacity. One key question is 
whether our animal findings closely reflects the patient scenario? Unfortunately, as of yet, 
no patient studies have evaluated skeletal muscle biopsies following endurance training in 
HFpEF. While data from an experimental rat model have shown HIIT attenuates 
mitochondrial and contractile impairments in the soleus [4], this study induced HFpEF by 
hypertension alone (rather than multiple comorbidities) and the endurance training was 
extensive lasting a total of 28 weeks. As such, limitations to both patient and animal 
studies preclude the degree to which we can conclude how much endurance training 
benefits skeletal muscle in HFpEF, but clearly this remains a ‘hot-topic’ of investigation.   
 
By inference, therefore, our data do not support the concept that an increases in  ̇  peak in 
HFpEF post-training is underpinned by improvements at the skeletal muscle level. In broad 
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terms,  ̇  peak is determined by products of the Fick principle (i.e. cardiac output and 
arterial-venous O2 difference). As our in vivo and in vitro measures of cardiac function 
were not improved post-training in HFpEF (which in fact agrees with many patient studies; 
as reviewed in ref. [23]), we speculate the main mechanism responsible for the increase in 
 ̇  peak likely resides at the peripheral vascular level [30, 31]. Indeed patients with HFpEF 
are known to have endothelial dysfunction [32] and we have previously shown endurance 
training can reverse in vitro endothelial dysfunction in aortic rings isolated from 
hypertensive rats with HFpEF [33]. However, endothelial dysfunction as a main 
mechanism of limitation in HFpEF remains controversial based on a key patient study 
showing endurance training over 16 weeks failed to improve endothelial function [27]. 
Nevertheless, the same authors haven also provided data to support that an increase in 
the arterial-mixed venous O2 difference is likely the primary mechanism underlying the 
higher  ̇  peak achieved post-training in HFpEF [26, 27], which indicates a peripheral 
limitation is present in HFpEF. Based on these data and together with our findings, we 
speculate improved microvascular perfusion may be the primary mechanism leading to an 
improvements in  ̇  peak following endurance training in HFpEF (which is known to be 
impaired [30, 31]), as this would be predicted to elevate O2 diffusion delivery from capillary 
to mitochondria (as dictated by Fick’s Law) [34].    
 
Conclusion 
Obesity-related HFpEF caused detrimental alterations to both slow-oxidative and fast-
glycolytic skeletal muscles, which included substantial fiber atrophy, a reduction in 
capillarity, a shift towards glycolytic metabolism, autophagy dysregulation, as well as 
impaired contractile functional measures. The intervention of exercise training (either high- 
or moderate-intensity treadmill running) was unable to attenuate many of these deficits, 
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which poses the intriguing question of whether endurance training can be used to combat 
skeletal muscle impairments induced by obesity-related HFpEF at the patient level.   
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Figure legends 
Fig 1. Characterization of the glycolytic EDL muscle at 20 weeks of age in control (Con) and to 
HFpEF rats, with representative muscle sections stained with an antibody against vWF to visualize 
capillaries presented for control (A) and HFpEF (B) rats (scale bar represents 100 μm). Mean fiber 
cross-sectional area (CSA) was severely reduced in HFpEF compared to control rats (C), as was 
the capillary-to-fiber ratio (D). As a marker of glycolytic metabolism, lactate dehydrogenase (LDH) 
activity was assessed, which tended to be higher in HFpEF rats (E), while LC3 II/I protein levels 
were assessed to provide an index of autophagy and these were depressed in HFpEF compared 
to controls (F). In vitro muscle function of the EDL was also assessed and this was impaired in 
HFpEF rats, with lower absolute forces generated compared to controls at higher stimulation 
frequencies (G) while relative fatigue was not influenced (H). n = 8 for Con and n = 12 for 
HFpEF. *P<0.05 vs. Con.     
 
Fig 2. Characterization of the oxidative soleus muscle at 20 weeks of age in control (Con) and to 
HFpEF rats, with representative muscle sections stained with an antibody against vWF to visualize 
capillaries presented for control (A) and HFpEF (B) rats (scale bar represents 100 μm). Mean fiber 
cross-sectional area (CSA) was lower in HFpEF compared to control rats (C), as was capillary-to-
fiber ratio (D). While lactate dehydrogenase (LDH) activity (E) and LC3 II/I protein levels (F) were 
not different between groups, in vitro absolute muscle forces were lower in HFpEF compared to 
control rats (G) but relative fatigue remained unchanged (H). n = 8 for Con and n = 12 for 
HFpEF. *P<0.05 vs. Con.     
 
Fig 3. Characterization of the glycolytic EDL muscle at 28 weeks of age following exercise training 
on a treadmill for the last 8 weeks, in control (Con) and HpEF rats that were assigned to either 
sedentary, high-intensity interval training (HIIT), and moderate-continuous training (MCT) groups 
for 8 weeks. Representative muscle sections (A) for each group are presented and have been 
stained with an antibody against vWF to visualize capillaries (scale bar represents 100 μm). Mean 
fiber cross-sectional area (CSA) was severely lower in all HFpEF groups compared to control rats 
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(B), as was the capillary-to-fiber ratio (C). Lactate dehydrogenase (LDH) was not different between 
groups, (D), however the protein levels of the autophagy marker LC3 tended to be lower in the 
HFpEF groups compared to controls (E). Absolute contractile forces were impaired in all HFpEF 
groups compared to controls (F), while fatigability was also greater in the HFpEF groups compared 
to controls early during the onset of repeated stimulations (G). *P<0.05 vs. Con.  
 
Fig 4. Characterization of the oxidative soleus muscle at 28 weeks of age following exercise 
training on a treadmill for 8 weeks, in control (Con) and HpEF rats that were assigned to either 
sedentary, high-intensity interval training (HIIT), and moderate-continuous training (MCT) groups. 
Representative muscle sections (A) for each group are presented and have been stained with an 
antibody against vWF to visualize capillaries (scale bar represents 100 μm). Mean fiber cross-
sectional area (CSA) was lower in all HFpEF groups compared to control rats (B), as was the 
capillary-to-fiber ratio (C). Lactate dehydrogenase (LDH) activity, as an index of reliance on 
glycolytic metabolism, was elevated only in sedentary HFpEF rats compared to controls (D), 
however autophagic flux, as measured by LC3 protein content, was increased in all the HFpEF 
groups (E). While absolute muscle forces were impaired in all HFpEF groups at the higher 
stimulation frequencies compared to control rats (F), fatigability was shown only to be greater in 
the HFpEF-HIIT group compared to controls (G). *P<0.05 vs. Con; #P<0.05 HFpEF-HIIT vs. Con.         
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